Satsuma Pharmaceuticals

Satsuma Pharmaceuticals

Developing best-in-class products to address the unmet needs of migraine sufferers.

HQ location
San Francisco, United States
Launch date
Employees
Market cap
$36.5m
Enterprise value
($5m)
Share price
$1.10 STSA
Authorizing premium user...